| International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma WD Travis, E Brambilla, M Noguchi, AG Nicholson, KR Geisinger, ... Journal of thoracic oncology 6 (2), 244-285, 2011 | 3927 | 2011 |
| Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer GV Scagliotti, P Parikh, J Von Pawel, B Biesma, J Vansteenkiste, ... Journal of clinical oncology 26 (21), 3543-3551, 2008 | 3496 | 2008 |
| Gefitinib in combination with paclitaxel and carboplatin in advanced non–small-cell lung cancer: a phase III trial—INTACT 2 RS Herbst, G Giaccone, JH Schiller, RB Natale, V Miller, C Manegold, ... Journal of Clinical Oncology 22 (5), 785-794, 2004 | 2140 | 2004 |
| Gefitinib in combination with gemcitabine and cisplatin in advanced non–small-cell lung cancer: a phase III trial—INTACT 1 G Giaccone, RS Herbst, C Manegold, G Scagliotti, R Rosell, V Miller, ... Journal of Clinical Oncology 22 (5), 777-784, 2004 | 2127 | 2004 |
| Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer J Valle, H Wasan, DH Palmer, D Cunningham, A Anthoney, A Maraveyas, ... New England Journal of Medicine 362 (14), 1273-1281, 2010 | 2030 | 2010 |
| First-Line Crizotinib versus Chemotherapy in ALK-Positive Lung Cancer BJ Solomon, T Mok, DW Kim, YL Wu, K Nakagawa, T Mekhail, E Felip, ... New England Journal of Medicine 371 (23), 2167-2177, 2014 | 1995 | 2014 |
| Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE Collaborative Group JP Pignon, H Tribodet, GV Scagliotti, JY Douillard, FA Shepherd, ... Journal of clinical oncology 26 (21), 3552-3559, 2008 | 1598 | 2008 |
| Phase III randomized trial comparing three platinum-based doublets in advanced non–small-cell lung cancer GV Scagliotti, F De Marinis, M Rinaldi, L Crino, C Gridelli, S Ricci, ... Journal of Clinical Oncology 20 (21), 4285-4291, 2002 | 1138 | 2002 |
| Randomized, double-blind study of denosumab versus zoledronic acid in the treatment of bone metastases in patients with advanced cancer (excluding breast and prostate cancer … DH Henry, L Costa, F Goldwasser, V Hirsh, V Hungria, J Prausova, ... J Clin Oncol 29 (9), 1125-1132, 2011 | 1008 | 2011 |
| The differential efficacy of pemetrexed according to NSCLC histology: a review of two Phase III studies G Scagliotti, N Hanna, F Fossella, K Sugarman, J Blatter, P Peterson, ... The oncologist 14 (3), 253-263, 2009 | 768 | 2009 |
| Randomized study of adjuvant chemotherapy for completely resected stage I, II, or IIIA non–small-cell lung cancer GV Scagliotti, R Fossati, V Torri, L Crino, G Giaccone, G Silvano, ... Journal of the National Cancer Institute 95 (19), 1453-1461, 2003 | 725 | 2003 |
| Prevalence of adrenal incidentaloma in a contemporary computerized tomography series S Bovio, A Cataldi, G Reimondo, P Sperone, S Novello, A Berruti, ... Journal of endocrinological investigation 29 (4), 298-302, 2006 | 570 | 2006 |
| Squamous cell carcinoma of the lung compared with other histotypes shows higher messenger RNA and protein levels for thymidylate synthase P Ceppi, M Volante, S Saviozzi, I Rapa, S Novello, A Cambieri, ... Cancer 107 (7), 1589-1596, 2006 | 477 | 2006 |
| Phase III study of carboplatin and paclitaxel alone or with sorafenib in advanced non-small-cell lung cancer G Scagliotti, S Novello, J Von Pawel, M Reck, JR Pereira, M Thomas, ... J Clin Oncol 28 (11), 1835-1842, 2010 | 456 | 2010 |
| ERCC1 and RRM1 gene expressions but not EGFR are predictive of shorter survival in advanced non-small-cell lung cancer treated with cisplatin and gemcitabine P Ceppi, M Volante, S Novello, I Rapa, KD Danenberg, PV Danenberg, ... Annals of Oncology 17 (12), 1818-1825, 2006 | 445 | 2006 |
| Gemcitabine and cisplatin versus mitomycin, ifosfamide, and cisplatin in advanced non–small-cell lung cancer: A randomized phase III study of the Italian Lung Cancer Project L Crino, GV Scagliotti, S Ricci, F De Marinis, M Rinaldi, C Gridelli, ... Journal of Clinical Oncology 17 (11), 3522-3530, 1999 | 426 | 1999 |
| Cisplatin-gemcitabine combination in advanced non-small-cell lung cancer: a phase II study L Crino, G Scagliotti, M Marangolo, F Figoli, M Clerici, F De Marinis, ... Journal of clinical oncology 15 (1), 297-303, 1997 | 422 | 1997 |
| Lung cancer: current therapies and new targeted treatments FR Hirsch, GV Scagliotti, JL Mulshine, R Kwon, WJ Curran Jr, YL Wu, ... The Lancet 389 (10066), 299-311, 2017 | 413 | 2017 |
| Multicenter, phase II trial of sunitinib in previously treated, advanced non–small-cell lung cancer MA Socinski, S Novello, JR Brahmer, R Rosell, JM Sanchez, CP Belani, ... Journal of clinical oncology: official journal of the American Society of …, 2008 | 374 | 2008 |
| Efficacy of gemcitabine plus platinum chemotherapy compared with other platinum containing regimens in advanced non-small-cell lung cancer: a meta-analysis of survival outcomes T Le Chevalier, G Scagliotti, R Natale, S Danson, R Rosell, R Stahel, ... Lung cancer 47 (1), 69-80, 2005 | 366 | 2005 |
